idarubicin
Ligand Summary
An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.
UNII: ZRP63D75JW
PubChem: 42890
ChEMBL: CHEMBL1117
DrugCentral: 1414
LyCHI: LAYGFF7BPKK9
Target Activities
1 Activities
Items per page:
10
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
INHIBITOR | ||||||